Host Defense® Launches New Mushroom Gummies, Expanding Access to Functional Mushroom Wellness*
The initial launch includes two formulas: Lion's Mane and Stamets 7® Formula Immune* gummies—made with certified organic mushroom mycelium grown in Washington state.*
Featuring "The Smart Mushroom," Host Defense® Lion's Mane gummies offer support for mental clarity, focus, memory, and mood while promoting nervous system health. Focus has a new favorite flavor with these blueberry-infused gummies, plus other natural flavors.*
Stamets 7® Formula Immune* gummies deliver Paul Stamets' signature seven-species mushroom mycelium blend in a strawberry-flavored gummy, with other natural flavors. A daily support for whole-body wellness, the formulation is designed to promote an engaged and balanced immune response in healthy individuals.*
Both gummy formulas are certified organic, non-GMO, vegan, gluten-free, and verified for quality and safety. With only 4 grams of sugar per serving and no artificial sweeteners, Host Defense Gummies are a tasty alternative to capsules, extracts, and powders.*
"We're incredibly excited to bring Host Defense Gummies to life," said
The launch represents the next evolution of Host Defense's mission to build a bridge between people and fungi while supporting accessible, everyday wellness through mushroom-based supplements.*
Host Defense Gummies are now available through select retailers and online at HostDefense.com.
About Host Defense® Mushrooms™
Host Defense was founded by world-renowned mushroom expert
Follow Host Defense on TikTok, Instagram, and Facebook.*
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
View original content to download multimedia:https://www.prnewswire.com/news-releases/host-defense-launches-new-mushroom-gummies-expanding-access-to-functional-mushroom-wellness-302718122.html
SOURCE Fungi Perfecti, LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC Novel-Payload Platform
- Atmofizer Technologies Inc. Announces Shareholder Approval and Conditional CSE Approval of Business Combination, New Incentive Compensation Plan and Shares-for-Debt Settlements
- Snipp Interactive Reports Q2 2026 Financial Results; Returns to Positive EBITDA on Highest Quarterly Revenue in Five Quarters
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share